Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.44 |
| ▸ | PDE4A | P27815 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | CASP1 | P29466 | 1/20 | 0.43 |
| ▸ | CASP7 | P55210 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | NQO2 | P16083 | 3/20 | 0.39 |
| ▸ | GAPDH | P04406 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | PKM | P14618 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16436398 | 0.91 | KDM4E (0.40) | ELANEPDE4AKMT2AKDM4EMAPT | |
| SCHEMBL16436196 | 0.90 | ELANE (0.53) | ELANEKMT2AKDM4EMAPTCYP3A4 | |
| SCHEMBL16436209 | 0.89 | ELANE (0.43) | ELANEPDE4AKMT2AKDM4EMAPT | |
| SCHEMBL16436282 | 0.88 | ELANE (0.51) | ELANEKMT2AKDM4EMAPTCYP3A4 | |
| SCHEMBL16436315 | 0.88 | ELANE (0.42) | ELANEPDE4AKMT2AKDM4EMAPT | |
| SCHEMBL16436317 | 0.86 | ELANE (0.44) | ELANEKMT2AKDM4EMAPTCYP3A4 | |
| SCHEMBL16436385 | 0.86 | ELANE (0.44) | ELANEKMT2AKDM4EMAPTCYP3A4 | |
| SCHEMBL16436429 | 0.86 | ELANE (0.47) | ELANEKMT2AKDM4EMAPTCYP3A4 | |
| SCHEMBL16436380 | 0.85 | KMT2A (0.38) | ELANEPDE4AKMT2AKDM4EMAPT | |
| SCHEMBL16436399 | 0.85 | KDM4E (0.40) | ELANEPDE4AKMT2AKDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9315603-B2 | Polymerizable compound having oxygen-containing five-membered ring, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2016-04-19 | — | — | US | disclosed |
| US-9315603-B2 | Polymerizable compound having oxygen-containing five-membered ring, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2016-04-19 | — | — | US | disclosed |
| US-20150034871-A1 | POLYMERIZABLE COMPOUND HAVING OXYGEN-CONTAINING FIVE-MEMBERED RING, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2015-02-05 | — | — | US | disclosed |
| US-20150034871-A1 | POLYMERIZABLE COMPOUND HAVING OXYGEN-CONTAINING FIVE-MEMBERED RING, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2015-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150034871-A1 | POLYMERIZABLE COMPOUND HAVING OXYGEN-CONTAINING FIVE-MEMBERED RING, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | OCIAD1, OCIAD2, SCO2 | ELANE 2946/4885PDE4A 3691/4885KMT2A 3863/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.